Despite being poised to enter the Republican Senate primary race for the second time in two weeks, Princeton biotech executive John Crowley once again withdrew his name from consideration today.
“John was deeply impressed with the outpouring of support for his potential candidacy for the US Senate. Many people both locally here in New Jersey and nationally had been encouraging him to run over the past week, but given his tremendous level of responsibility to his family, his company and to the US Navy, he’s decided not to enter the US Senate race this year,” said Crowley’s friend and advisor, Bill Spadea. “I know there was a lot of legitimate anticipation that John would enter this race we’ve been upfront with the many obligations he has, and his decision had to come down to his family.”
There were other considerations as well, like Crowley’s role as CEO of Amicus Therapeutics and whether he would be able to disentangle himself from company affairs soon enough to declare a candidacy.
“Given that he was the CEO of a public company it was very challenging, specifically given the very condensed time frame,” said Spadea.
Collecting signatures was not an obstacle, however. Over the last two weeks, Crowley’s volunteers gathered 2,200 of them.